Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

Combination effect of epsilon-poly-L-lysine and antibiotics against common bacterial pathogens

Abstract

Epsilon-poly-l-lysine (EPL) is an antimicrobial peptide with low mammalian toxicity; thus, it is commonly used as food preservative. Here, the capacity of EPL to improve the efficacy of the antibiotics ampicillin (AMP), gentamycin (GEN), tetracycline (TCN), and methicillin (MET) against four bacterial pathogens, namely Pseudomonas aeruginosa PAO1, Klebsiella pneumoniae CG43, MET-sensitive Staphylococcus aureus ATCC 25923 (MSSA), and MET-resistant S. aureus ATCC 33591 (MRSA), was investigated. Some antibiotic–EPL combinations, i.e., AMP–EPL, GEN–EPL, and TCN–EPL, were particularly active against the pathogens through synergy, partial synergy, or additive effects. Additionally, MET–EPL displayed a partial synergistic effect against MRSA. GEN–EPL had the most powerful antimicrobial effect against MSSA: it eradicated the bacterium within an hour. Conversely, AMP–EPL and MET–EPL were the least potent combinations against MRSA, and TCN–EPL was least potent against K. pneumoniae; for these combinations, bactericidal activities occurred >10 h after initial treatments. All antibiotic–EPL treatments showed inhibitory activities against P. aeruginosa biofilm formation and enhanced preformed biofilm disruption in vitro. Similarly, the inhibition of biofilm formation on a porcine skin model was observed. Moreover, no significant cytotoxicity was detected for any antibiotic–EPL treatment in tests using Balb/3t3 fibroblasts. Given the rise in antibiotic-resistant bacteria, combining antibiotics with EPL may enhance antibiotic effectiveness, as shown in this study, while helping to avoid antimicrobial resistance.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2

References

  1. Tyers M, Wright GD. Drug combinations: a strategy to extend the life of antibiotics in the 21st century. Nat Rev Microbiol. 2019;17:141–55.

    Article  CAS  Google Scholar 

  2. Geitani R, Ayoub Moubareck C, Touqui L, Karam Sarkis D. Cationic antimicrobial peptides: alternatives and/or adjuvants to antibiotics active against methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa. BMC Microbiol. 2019;19:1–12.

    Article  Google Scholar 

  3. Grassi L, Maisetta G, Esin S, Batoni G. Combination strategies to enhance the efficacy of antimicrobial peptides against bacterial biofilms. Front Microbiol. 2017;8:2409.

    Article  Google Scholar 

  4. Shukla SC, Singh A, Pandey A, Mishra A. Review on production and medical applications of ɛ-polylysine. Biochem Eng J. 2012;65:78–81.

    Article  Google Scholar 

  5. Yoshida T, Nagasawa T. ε-Poly-L-lysine: microbial production, biodegradation and application potential. Appl Microbiol Biotechnol. 2003;62:21–6.

    Article  CAS  Google Scholar 

  6. Ning H-Q, Lin H, Wang J-X. Synergistic effects of endolysin Lysqdvp001 and ε-poly-lysine in controlling Vibrio parahaemolyticus and its biofilms. Int J Food Microbiol. 2021;343:109112.

    Article  CAS  Google Scholar 

  7. Najjar MB, Kashtanov D, Chikindas M. ε‐Poly‐l‐lysine and nisin A act synergistically against Gram‐positive food‐borne pathogens Bacillus cereus and Listeria monocytogenes. Lett Appl Microbiol. 2007;45:13–8.

    Article  CAS  Google Scholar 

  8. Zhou C, Li P, Qi X, Sharif AR, Poon YF, Cao Y et al. A photopolymerized antimicrobial hydrogel coating derived from epsilon-poly-l-lysine. Biomaterials. 2011;32:2704–12.

    Article  CAS  Google Scholar 

  9. Hyldgaard M, Mygind T, Vad BS, Stenvang M, Otzen DE, Meyer RL. The antimicrobial mechanism of action of epsilon-poly-l-lysine. Appl Environ Microbiol. 2014;80:7758–70.

    Article  Google Scholar 

  10. Zahi MR, El Hattab M, Liang H, Yuan Q. Enhancing the antimicrobial activity of d-limonene nanoemulsion with the inclusion of ε-polylysine. Food Chem. 2017;221:18–23.

    Article  CAS  Google Scholar 

  11. Yoshida T, Nagasawa T.ε-Poly-L-lysine: microbial production, biodegradation and application potential.Appl Microbiol Biotechnol.2003;62:21–6.

    Article  CAS  Google Scholar 

  12. Tan Z, Shi Y, Xing B, Hou Y, Cui J, Jia S. The antimicrobial effects and mechanism of ε-poly-lysine against Staphylococcus aureus. Bioresour Bioprocess. 2019;6:1–10.

    Article  Google Scholar 

  13. Koebnik R, Locher KP, Van Gelder P. Structure and function of bacterial outer membrane proteins: barrels in a nutshell. Mol Microbiol. 2000;37:239–53.

    Article  CAS  Google Scholar 

  14. Berditsch M, Jäger T, Strempel N, Schwartz T, Overhage J, Ulrich AS. Synergistic effect of membrane-active peptides polymyxin B and gramicidin S on multidrug-resistant strains and biofilms of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2015;59:5288–96.

    Article  CAS  Google Scholar 

  15. Chang Y, McLandsborough L, McClements DJ. Cationic antimicrobial (ε-polylysine)–anionic polysaccharide (pectin) interactions: influence of polymer charge on physical stability and antimicrobial efficacy. J Agric Food Chem. 2012;60:1837–44.

    Article  CAS  Google Scholar 

  16. Guzel Kaya G, Medaglia S, Candela-Noguera V, Tormo-Mas MÁ, Marcos MD, Aznar E et al. Antibacterial activity of linezolid against gram-negative bacteria: utilization of ε-poly-l-lysine capped silica xerogel as an activating carrier. Pharmaceutics. 2020;12:1126.

    Article  CAS  Google Scholar 

  17. Shi C, Zhao X, Liu Z, Meng R, Chen X, Guo N. Antimicrobial, antioxidant, and antitumor activity of epsilon-poly-L-lysine and citral, alone or in combination. Food Nutr Res. 2016;60:31891.

    Article  Google Scholar 

  18. Standards, N.C.f.C.L. and Barry AL. Methods for determining bactericidal activity of antimicrobial agents: approved guideline. National Committee for Clinical Laboratory Standards Wayne, PA; 19. 1999.

  19. Garty BZ, Offer I, Livni E, Danon YL. Erythema multiforme and hypersensivity myocarditis caused by ampicillin. Ann Pharmacother. 1994;28:730–1.

    Article  CAS  Google Scholar 

  20. Guin J, Phillips D. Erythroderma from systemic contact dermatitis: a complication of systemic gentamicin in a patient with contact allergy to neomycin. Cutis. 1989;43:564–7.

    CAS  PubMed  Google Scholar 

  21. Bjellerup M, Ljunggren B. Photohemolytic potency of tetracyclines. J Investig Dermatol. 1985;84:262–4.

    Article  CAS  Google Scholar 

  22. Yow MD, Taber LH, Barrett FF, Mintz AA, Blankinship GR, Clark GE et al. A ten-year assessment of methicillin-associated side effects. Pediatrics. 1976;58:329–34.

    Article  CAS  Google Scholar 

  23. Wang R, Xu D, Liang L, Xu T, Liu W, Ouyang P et al. Enzymatically crosslinked epsilon-poly-L-lysine hydrogels with inherent antibacterial properties for wound infection prevention. RSC Adv. 2016;6:8620–7.

    Article  CAS  Google Scholar 

  24. Guo Z, Sui J, Ma M, Hu J, Sun Y, Yang L et al. pH-Responsive charge switchable PEGylated ε-poly-l-lysine polymeric nanoparticles-assisted combination therapy for improving breast cancer treatment. J Controlled Release. 2020;326:350–64.

    Article  CAS  Google Scholar 

  25. Palmer J, Flint S, Brooks J. Bacterial cell attachment, the beginning of a biofilm. J Ind Microbiol Biotechnol. 2007;34:577–88.

    Article  CAS  Google Scholar 

  26. Davison WM, Pitts B, Stewart PS. Spatial and temporal patterns of biocide action against Staphylococcus epidermidis biofilms. Antimicrob Agents Chemother. 2010;54:2920–7.

    Article  CAS  Google Scholar 

  27. Martinez M, Gonçalves S, Felício MR, Maturana P, Santos NC, Semorile L et al. Synergistic and antibiofilm activity of the antimicrobial peptide P5 against carbapenem-resistant Pseudomonas aeruginosa. Biochimica Biophys Acta (BBA)—Biomembr. 2019;1861:1329–37.

    Article  CAS  Google Scholar 

  28. Shi D, Mi G, Wang M, Webster TJ. In vitro and ex vivo systems at the forefront of infection modeling and drug discovery. Biomaterials. 2019;198:228–49.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work is supported by the Ministry of Science and Technology (MOST) (Grant number: 109-2320-B-007-007-MY3), Taiwan.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hwan-You Chang.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sundaran, S., Kok, LC. & Chang, HY. Combination effect of epsilon-poly-L-lysine and antibiotics against common bacterial pathogens. J Antibiot 75, 354–359 (2022). https://doi.org/10.1038/s41429-022-00523-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41429-022-00523-9

This article is cited by

Search

Quick links